Press Releases

You Narrowed By: Business/Product Release

Showing 36-70 of 115


2013

March

March 4

Abbott Introduces Nutrition for Active Kids - Kidz ZonePerfect® Nutrition Bars
 

February

February 21

Abbott to Collaborate with Janssen and Pharmacyclics on Development of Companion Test for Investigational Leukemia Therapy

February 12

New Survey Reveals Eight in 10 Fitness Enthusiasts Are Not Doing Enough to Aid Recovery After Exercise
 

January

January 9

New Abbott Test Available in Europe Provides Novel Tool to Aid Doctors in Evaluating Potential Heart Attacks

January 8

Abbott Initiates Clinical Trial of Absorb™ in the United States

January 3

Abbott Announces FDA Approval and U.S. Launch of Next-Generation XIENCE Xpedition™ Drug Eluting Stent System

January 2

Abbott Completes Separation of Research-Based Pharmaceuticals Business

2012

December

December 17

Abbott Announces New Testosterone Test to Measure the Hormone at Low Levels

December 17

AbbVie Inc. Common Stock Approved for Listing on NYSE Euronext Paris

December 13

New Study Shows Promising Results For Tests That Can Help Doctors Better Evaluate Potential Heart Attacks
 

November

November 27

Abbott’s HUMIRA® (Adalimumab) Approved in Europe for Severe Active Pediatric Crohn’s Disease

November 13

Abbott Announces Phase 3 Hepatitis C Program Details

November 12

Abbott Announces First Long-term Patient-reported Health Outcomes Data for Investigational Use of HUMIRA® (Adalimumab) in Patients with Active Non-Radiographic Axial Spondyloarthritis (nr-axSpA)

November 12

Abbott Announces Results of Analysis Exploring the Use of HUMIRA® (Adalimumab) in Simultaneously Achieving Three Key Treatment Goals for Rheumatoid Arthritis

November 10

Abbott Presents Promising Phase 2b Interferon-free Hepatitis C Results at 2012 Liver Meeting®
 

October

October 30

Abbott Introduces Ensure Complete™ Shakes For Adults

October 24

Abbott Announces Data Evaluating Reduction of Steroid Usage with HUMIRA® (Adalimumab) in Patients with Moderately to Severely Active Ulcerative Colitis

October 24

Abbott’s ALK Test is Now Available in Europe as a Companion Diagnostic Test to Aid in Identifying Patients for Targeted Lung Cancer Therapy

October 23

Abbott Announces New Data Evaluating Mucosal Healing with HUMIRA® (Adalimumab) in Patients with Moderately to Severely Active Ulcerative Colitis

October 22

Abbott Announces Three-Year Long-Term Data Evaluating Efficacy with HUMIRA® (Adalimumab) For Patients with Moderately to Severely Active Ulcerative Colitis

October 19

Abbott Receives Positive Opinion from CHMP for HUMIRA® Use in Pediatric Crohn's Disease

October 15

Abbott's Investigational Interferon-Free Hepatitis C Treatment Regimen Achieved SVR12 (Observed Data) Rates in 99 Percent of Treatment-Naïve and 93 Percent in Prior Null Responders for Genotype 1 Patients in Phase 2b Study
 

September

September 28

Abbott's HUMIRA® (adalimumab) Receives U.S. FDA Approval for the Treatment of Adult Patients with Moderate to Severe Ulcerative Colitis

September 25

Abbott Announces International Launch of the Absorb™ Bioresorbable Vascular Scaffold

September 12

According to New Survey, Most Men are Not Proactive about Their Health Despite the Desire to Live Long Lives

September 6

Abbott to Collaborate with Astellas in CMV Vaccine Trial
 

August

August 30

Abbott's HUMIRA® (Adalimumab) Approved in Europe for Expanded Treatment of Crohn’s Disease (CD)

August 28

Abbott Announces CE Mark for Highly Sensitive Testosterone Test to Measure the Hormone at Low Levels

August 20

Abbott Announces CE Mark and European Launch of Next-Generation XIENCE Xpedition™ Drug Eluting Stent

August 7

Abbott's Omnilink Elite® Vascular Balloon-Expandable Stent System Receives FDA Approval for Treatment of Iliac Artery Disease
 

July

July 30

Abbott's HUMIRA® (adalimumab) Approved in Europe for Treatment of Non-radiographic Axial Spondyloarthritis (nr-axSpA)

July 13

Abbott Focuses on the Importance of Information Management and Automation at the American Association for Clinical Chemistry Lab Expo

July 11

Abbott Introduces OneLab, a Novel Integrated Web-Based Software Platform to Manage the Vast Amounts of Information Flowing Through the Lab

July 10

Abbott Announces New Test for the Management of Patients with Diabetes

July 3

Abbott Receives FDA Approval for Healon EndoCoat Protective Gel for Cataract Surgery